Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Biomarkers in Ovarian Cancer: Early Detection and Chemoresistance

March 4th 2011

Worldwide, there are ~204,000 new cases of ovarian cancer each year, accounting for 4% of cancers diagnosed in women.

South Florida's Sylvester Comprehensive Cancer Center: Hitting Its Stride

March 2nd 2011

The Sylvester Comprehensive Cancer Center (SCCC), part of the University of Miami Health System, first opened its doors in 1992. Over the years, the SCCC has become the hub of cancer research in the region.

Yale Cancer Center: Innovation Abounds in New Facilities

March 2nd 2011

In 1974 the National Cancer Institute designated Yale Cancer Center as one of the country's inaugural comprehensive cancer centers.

Clinical Trial Reports: September 2007

July 8th 2010

The Clinical Trials reported in this issue include: PHASE IV: Obesity a Major Risk Factor for Multiple Myeloma PHASE III: 1) Long-Term Safety of Adjuvant Trastuzumab (Herceptin) 2) Bevacizumab (Avastin) Helps Slow Tumor Growth in Patients with Advanced or Recurrent Non-Small-Cell Lung Cancer 3) Addition of Bevacizumab To Interferon Alfa 2a Nearly Doubles Median Progression-Free Survival in Patients with Previously Untreated Advanced Kidney Cancer, and more

Clinical Trial Reports: July/August 2007

July 7th 2010

Among the Clinical Trials reported in this issue are: PHASE III: 1) More Positive News in GPC Biotech's Trial With Satraplatin 2) Sanofi-Aventis Presents Positive Results in Three Oncology Programs 3) Imatinib (Gleevec) After GIST Surgery Achieves Significant Survival Benefit, and more

Clinical Trial Reports: October 2007

June 30th 2010

The Clinical Trials reported include: PHASE III: 1) Is Combination or Sequential Treatment for Metastatic Colorectal Cancer More Effective? 2) Cervical Cancer Vaccines Do Not Work Like Investigational Cancer Vaccines, Study Confirms 3) Docetaxel to Improve Clinical and Quality of Life Improvement in the Treatment of Advanced Gastric or Gastroesophageal Cancer, and more

Clinical Trial Reports: November 2007

June 29th 2010

The Clinical Trials Reported in this issue include: PHASE III: 1) Trastuzumab and Anastrozole Extend Breast Cancer Survival in Patients Who Received Anastrozole Alone Earlier PHASE II: 1) Motexafin for Non%u2013Small Cell Lung Cancer 2) Oral Satraplatin Monotherapy for the Treatment of Metastatic Breast Cancer Shows Little Response, and more

Clinical Trial Reports: May 25, 2010

May 25th 2010

Clinical trials covered include: 1) Phase III: Quality of Life with Sunitinib or Interferon Alfa for Patients with Metastatic Renal Cell Carcinoma 2) Phase II: Children%u2019s Oncology Group Pilot Study, and more

Opportunities and Challenges: A Time to Reflect at the End of a Busy Year

December 29th 2008

It is the final month of what has been economically a very tough year. Oncology centers and practices continue to face declining reimbursements on all service lines, and most have had either flat or lower revenues.

One Last Look back: The 10 Biggest Health IT Stories of 2008

December 17th 2008

Some of the Top Health IT Stories from 2008 are discussed.

The Inner Frontier: Exploring the Brave New World of Personalized Medicine

February 13th 2008

Currently available pharmaceutical therapies for many chronic illnesses leave much to be desired.